COPD care in Saudi Arabia: physicians' awareness and knowledge of guidelines and barriers to implementation

Alsubaiei, Mohammed E; Frith, Peter; Cafarella, Paul; Quinn, Stephen; Moamary, Mohamed S Al; McEvoy, R. Doug; Effing, Tanja

doi:10.5588/ijtld.16.0656

Cited by 15 publications

(16 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In COPD, some specific variables, largely described by López-Campos et al [12], are associated with PTG adherence. Some of them are physician-(e.g., knowledge), patient-(e.g., understanding), and/or social-(e.g., costs of medication) related factors [17][18][19][20][21][22][23]. The Tunisian pulmonologists' adherence to the 2017-GOLD PTGs is influenced by the patients' age, SEL, national health insurance coverage, and GOLD groups ( Table 5).…”

Section: Discussion Of Results the Evaluation Of Pulmonologists'mentioning

confidence: 99%

Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD)

Aissa

Knaz

Maatoug

et al. 2020

BioMed Research International

View full text Add to dashboard Cite

Background. No previous study has investigated the adherence rate of North-African pulmonologists to the 2017-GOLD PTGs. Aims. To investigate the adherence rate of Tunisian pulmonologists to the 2017-GOLD PTGs and to identify the barriers to their adherence. Methods. This was a cohort study involving clinically stable COPD patients who presented to a pulmonology outpatient consultation. The patients were classified as having been appropriately and inappropriately (over- or undertreatment) treated for the GOLD group. Logistic regression was performed to determine the adherence barriers to the 2017-GOLD PTGs. Results. A total of 296 patients were included (88.1% males, mean age: 68±10 years; GOLD A (7.1%), B (36.1%), C (4.1%), and D (52.7%)). The pulmonologists’ adherence rate to the 2017-GOLD PTGs was 29.7%. There was a significant statistical difference between the adherence rates among the four GOLD groups (A: 19.0%, B: 20.6%, C: 8.3%, and D: 39.1%; p=0.001). Differences were statistically significant between the GOLD group D and groups B (p=0.001) and C (p=0.033). The multivariate analysis showed that age (odds ratio (OR): 0.968), socioeconomic level (high/medium vs. low; OR: 2.950), insurance type (national health insurance vs. others; OR: 2.851), and GOLD groups (A/B vs. C/D; OR: 3.009) significantly influenced the adherence rate to the 2017-GOLD PTGs. Conclusion. The adherence rate of Tunisian pulmonologists to the 2017-GOLD PTGs is low. It seems that the patients’ age, socioeconomic level, national health insurance coverage, and GOLD groups influenced their adherence.

show abstract

Section: Discussion Of Results the Evaluation Of Pulmonologists'mentioning

confidence: 99%

Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD)

Aissa

Knaz

Maatoug

et al. 2020

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…[ 43 44 ] Many physicians and pulmonologists are, however, unaware of or have poor understanding of and adherence to the GOLD and SICAD recommendations for the management of COPD in many countries including Saudi Arabia. [ 43 45 ] This may be a result of, for example, time constraints or disagreement with the recommendations. [ 43 44 ] It is important to increase the physician's awareness of COPD guidelines to improve COPD management[ 44 ] and decrease morbidity and mortality rates.…”

Section: Lack Of Awareness Of Evidence-based Practice Guidelines To Mmentioning

confidence: 99%

“…It is clear that the high prevalence of smoking in Saudi Arabia, the low number of chest physicians and poor compliance to the COPD guidelines increase the burden of respiratory diseases such as COPD. [ 2 14 43 44 45 ] Whereas, the factors above should be considered when seeking to improve and optimize health care, knowledge of patient opinions regarding optimizing care would also be very useful. Further studies exploring patient opinions would most likely be very helpful.…”

Section: Lack Of Awareness Of Evidence-based Practice Guidelines To Mmentioning

confidence: 99%

Factors influencing management of chronic respiratory diseases in general and chronic obstructive pulmonary disease in particular in Saudi Arabia: An overview

et al. 2018

View full text Add to dashboard Cite

The prevalence of chronic obstructive pulmonary disease in Saudi Arabia is 4.2% among the general population and 14.2% among smokers. Studies showed that management of respiratory diseases is inadequate. In this article, we have elaborated on how factors as health economic factors, lack of health-care providers, culture, attitude, lifestyle (such as smoking and physical inactivity), and lack of adherence to the evidence-based practice guidelines may influence chronic respiratory disease management in Saudi Arabia. We have to conclude that these factors should be taken into account while seeking to improve and optimize the quality of care for patients with respiratory diseases in Saudi Arabia.

show abstract

“…12 The prevalence of COPD among the general population in Saudi Arabia is 4.2%, comparable with the reported prevalence rate of 3.6% in the entire Middle East. 13 Interestingly, in patients in Saudi Arabia, COPD does not progress to end-stage lung disease requiring lung transplantation, which is contrary to worldwide reports in which COPD is the most common cause for lung transplantation. More research is needed to investigate whether some genetic or environmental factors are responsible for such a marked difference.…”

Section: Discussionmentioning

confidence: 88%

The outcomes of 80 lung transplants in a single center from Saudi Arabia

Akram¹,

Nizami²,

Hussein

et al. 2019

Ann Saudi Med

View full text Add to dashboard Cite

BACKGROUND: Lung transplantation has become a standard of care for a select group of patients with advanced lung diseases. Lung transplantation has undergone rapid growth in the last few years in Saudi Arabia.OBJECTIVE: Describe five years of experience with lung transplantation.DESIGN: Retrospective, descriptive.SETTINGS: Major tertiary care hospital.PATIENTS: All patients who underwent lung transplant surgery between 2010 to 2015.MAIN OUTCOME MEASURES: Indications for lung transplant demographics, body mass index, blood group, type of transplant surgery, morbidity rate using the Clavien-Dindo classification, rate of early- and late-onset bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans-free survival, 30- and 90-day mortality rate, and survival (30 days, 90 days, 1-year, 3-years and 5-years) for lung transplant recipients. The duration of mechanical ventilation, colonization by bacteria and need for lung volume reduction surgery for lung donors.SAMPLE SIZE: 80, 45% women and 55% men.RESULTS: The most common indication for lung transplant in Saudi Arabia is pulmonary fibrosis (45%), followed by non-cystic fibrosis bronchiectasis (25%) and cystic fibrosis-related bronchiectasis (20%). Only 45% of our lung transplant recipients had a normal BMI (18-28 kg/m2). The most frequent blood group was A (40%), followed by blood group O (32.5%). Most (85%) lung transplants were bilateral while 15% were single lung transplants. Postoperative complications developed in 64 patients, 34 (42.5%) had minor grade 1 complications, while 13 (16.5%) had severe complications leading to death (grade V). Early onset BOS developed in 6 (7.5%) patients while 16 (20%) had late onset BOS. The BOS-free survival rate was 72.5%. The mean duration of mechanical ventilation in lung donors was 9 days and most were infected by bacteria. The majority of recipients required lung volume reduction. The 30-day mortality rate was 12.5% and the 90-day mortality rate was 17.5%. Survival rates at our center were 87.5% at 30 days, 82.5% at 90 days, 81.2% at 1 year, 67.9% at 2 years and 62.1% at 5 years.CONCLUSIONS: Lung transplantation has become an invaluable approach for the treatment of end-stage respiratory disease. Our 5-year experience has shown exciting promises for lung transplantation in Saudi Arabia.LIMITATIONS: Retrospective design, single center experience.CONFLICT OF INTEREST: None.

show abstract

COPD care in Saudi Arabia: physicians' awareness and knowledge of guidelines and barriers to implementation

Abstract: Saudi physicians' knowledge about Global Initiative for Chronic Obstructive Lung Disease guidelines was assessed as fair. It is therefore highly recommended to increase physicians' awareness and knowledge about COPD-related guidelines.

Cited by 15 publications

References 0 publications

Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD)

Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD)

Factors influencing management of chronic respiratory diseases in general and chronic obstructive pulmonary disease in particular in Saudi Arabia: An overview

The outcomes of 80 lung transplants in a single center from Saudi Arabia

Contact Info

Product

Resources

About